<abstract xmlns="http://www.w3.org/1999/xhtml"><p>People over the age of 65 and those suffering from chronic diseases, such as asthma, are part of the risk group for severe acute respiratory syndrome-COV-2 (SARS-CoV-2) infection. In the past, a connection between viral infections and asthma has been presented. Patients with asthma appear to be at risk of contracting viral infections, and also viruses can cause asthma exacerbations. Another concern during this period was about the chronic administration of corticosteroids in asthmatic patients, because of the consideration that corticosteroid therapy would decrease the immunity of these patients, thus increasing the risk of infections, including the infection with SARS-CoV-2. Thus, several questions have emerged about the role of corticosteroid therapy in the development of COVID-19 in patients undergoing corticosteroid treatment. Most guidelines recommend continuing the administration of chronic treatment to this category of patients. At the same time, the health system had to adapt to the situation caused by the COVID-19 pandemic and deviate from the standard methods of managing most chronic diseases and these changes had an impact on these category of patients.</p></abstract>

People over the age of 65 and those suffering from chronic diseases, such as asthma, are part of the risk group for severe acute respiratory syndrome-COV-2 (SARS-CoV-2) infection. In the past, a connection between viral infections and asthma has been presented. Patients with asthma appear to be at risk of contracting viral infections, and also viruses can cause asthma exacerbations. Another concern during this period was about the chronic administration of corticosteroids in asthmatic patients, because of the consideration that corticosteroid therapy would decrease the immunity of these patients, thus increasing the risk of infections, including the infection with SARS-CoV-2. Thus, several questions have emerged about the role of corticosteroid therapy in the development of COVID-19 in patients undergoing corticosteroid treatment. Most guidelines recommend continuing the administration of chronic treatment to this category of patients. At the same time, the health system had to adapt to the situation caused by the COVID-19 pandemic and deviate from the standard methods of managing most chronic diseases and these changes had an impact on these category of patients.

Challenges in the diagnosis, treatment and management of asthma during COVID-19 pandemic

University of Medicine and Pharmacy “Grigore T. Popa”

Pneumologia

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Provocări în diagnosticul, tratamentul și managementul astmului bronșic în pandemia COVID-19

People over the age of 65 and those suffering from chronic diseases, such as asthma, are part of the risk group for severe acute respiratory syndrome-COV-2...

Challenges in the diagnosis, treatment and management of asthma during COVID-19 pandemic

Article Category: Reviews

Publicado en línea: 31 dic 2020

Páginas: 73 - 80

DOI: https://doi.org/10.2478/pneum-2020-0021

Palabras clave
COVID-19, asthma, viral infections, corticotherapy

© 2020 Rohozneanu Oana Elena et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Challenges in the diagnosis, treatment and management of asthma during COVID-19 pandemic

Article Category: Reviews

Publicado en línea: 31 dic 2020

Páginas: 73 - 80

DOI: https://doi.org/10.2478/pneum-2020-0021

Palabras claveCOVID-19, asthma, viral infections, corticotherapy

© 2020 Rohozneanu Oana Elena et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Palabras clave
COVID-19, asthma, viral infections, corticotherapy